These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27599546)

  • 1. Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.
    Cooke RE; Gherardin NA; Harrison SJ; Quach H; Godfrey DI; Prince M; Koldej R; Ritchie DS
    J Transl Med; 2016 Sep; 14(1):259. PubMed ID: 27599546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications.
    Du MT; Bergsagel PL; Chesi M
    Hematol Oncol Clin North Am; 2024 Apr; 38(2):533-546. PubMed ID: 38233233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.
    Yee AJ; Bensinger WI; Supko JG; Voorhees PM; Berdeja JG; Richardson PG; Libby EN; Wallace EE; Birrer NE; Burke JN; Tamang DL; Yang M; Jones SS; Wheeler CA; Markelewicz RJ; Raje NS
    Lancet Oncol; 2016 Nov; 17(11):1569-1578. PubMed ID: 27646843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T Cell in Myeloma.
    Joshua D; Suen H; Brown R; Bryant C; Ho PJ; Hart D; Gibson J
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):537-542. PubMed ID: 27601001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.
    Kim SJ; Shin HT; Lee HO; Kim NK; Yun JW; Hwang JH; Kim K; Park WY
    Oncotarget; 2016 Oct; 7(42):68350-68359. PubMed ID: 27634910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.
    Xu L; Mohammad KS; Wu H; Crean C; Poteat B; Cheng Y; Cardoso AA; Machal C; Hanenberg H; Abonour R; Kacena MA; Chirgwin J; Suvannasankha A; Srour EF
    Cancer Res; 2016 Dec; 76(23):6901-6910. PubMed ID: 27634757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma.
    Crescenzi A; Annibali O; Bianchi A; Pagano A; Donati M; Grifoni A; Avvisati G
    Leuk Res; 2016 Oct; 49():98-101. PubMed ID: 27619200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
    Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
    Am J Pathol; 2016 Nov; 186(11):3054-3063. PubMed ID: 27648615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
    Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
    Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
    Avivi I; Cohen YC; Joffe E; Benyamini N; Held-Kuznetsov V; Trestman S; Terpos E; Dimopoulos MA; Kastritis E
    Hematol Oncol; 2017 Dec; 35(4):734-740. PubMed ID: 27641057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Do Myeloma, Breast Cancer, and Prostate Cancer Have in Common?
    Isaacs WB
    Eur Urol; 2017 Feb; 71(2):166-167. PubMed ID: 27600588
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.
    Ramji K; Grzywa TM; Sosnowska A; Paterek A; Okninska M; Pilch Z; Barankiewicz J; Garbicz F; Borg K; Bany-Laszewicz U; Zerrouqi A; Pyrzynska B; Rodziewicz-Lurzynska A; Papiernik D; Sklepkiewicz P; Kedzierska H; Staruch A; Sadowski R; Ciepiela O; Lech-Maranda E; Juszczynski P; Mackiewicz U; Maczewski M; Nowis D; Golab J
    Sci Rep; 2022 Nov; 12(1):19660. PubMed ID: 36385153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma.
    Bradey AL; Fitter S; Duggan J; Wilczek V; Williams CMD; Cheney EA; Noll JE; Tangseefa P; Panagopoulos V; Zannettino ACW
    Sci Rep; 2022 Jul; 12(1):13128. PubMed ID: 35908046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
    Croucher DC; Richards LM; Tsofack SP; Waller D; Li Z; Wei EN; Huang XF; Chesi M; Bergsagel PL; Sebag M; Pugh TJ; Trudel S
    Nat Commun; 2021 Nov; 12(1):6322. PubMed ID: 34732728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy.
    Meermeier EW; Welsh SJ; Sharik ME; Du MT; Garbitt VM; Riggs DL; Shi CX; Stein CK; Bergsagel M; Chau B; Wheeler ML; Bezman N; Wang F; Strop P; Bergsagel PL; Chesi M
    Blood Cancer Discov; 2021 Jul; 2(4):354-369. PubMed ID: 34258584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
    Pisano M; Cheng Y; Sun F; Dhakal B; D'Souza A; Chhabra S; Knight JM; Rao S; Zhan F; Hari P; Janz S
    Front Immunol; 2021; 12():667054. PubMed ID: 34149703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD36-mediated ferroptosis dampens intratumoral CD8
    Ma X; Xiao L; Liu L; Ye L; Su P; Bi E; Wang Q; Yang M; Qian J; Yi Q
    Cell Metab; 2021 May; 33(5):1001-1012.e5. PubMed ID: 33691090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy.
    Davis JE; Handunnetti SM; Ludford-Menting M; Sharpe C; Blombery P; Anderson MA; Roberts AW; Seymour JF; Tam CS; Ritchie DS; Koldej RM
    Blood Adv; 2020 Oct; 4(19):4849-4859. PubMed ID: 33031542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells.
    Cooke RE; Quinn KM; Quach H; Harrison S; Prince HM; Koldej R; Ritchie D
    Front Immunol; 2020; 11():2153. PubMed ID: 33013907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PINK1-Dependent Mitophagy Regulates the Migration and Homing of Multiple Myeloma Cells via the MOB1B-Mediated Hippo-YAP/TAZ Pathway.
    Fan S; Price T; Huang W; Plue M; Warren J; Sundaramoorthy P; Paul B; Feinberg D; MacIver N; Chao N; Sipkins D; Kang Y
    Adv Sci (Weinh); 2020 Mar; 7(5):1900860. PubMed ID: 32154065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.